Before a new treatment reaches patients in the MENA region, someone has to show it works in local practice, that it’s worth its cost, and how health systems can pay for it. CCHO helps you build that case, with regionally recognized, multilingual researchers who know how decisions are made in each market.
Studies based on data from everyday clinical practice in the region, to support value and access decisions.
Learn moreMeasuring what matters to patients: PROMs and PREMs selection, development, validation and Arabic adaptation.
Learn moreCost-effectiveness, budget impact and burden-of-disease studies built for MENA health systems.
Learn moreHEOR, HTA and market access workshops in English, French and Arabic.
Learn moreValue dossiers, regulatory submissions and scientific publications.
Learn moreTell us about your value, evidence or access challenge and we will shape the right combination.
Request a consultationOur multidisciplinary team works across the entire product lifecycle, bringing together health economics, real-world evidence, patient-reported outcomes, epidemiology, biostatistics, advanced data analytics and health policy.
Tell us about your evidence or access challenge in the MENA region. We reply within two business days.
